Today's Rundown Featured Story | | | Monday, July 29, 2019 A phase 2 trial of Cidara Therapeutics’ antifungal prospect rezafungin has met its objectives. The trial found the drug performed numerically better than Merck’s Cancidas, offering Cidara encouragement as it heads toward phase 3 data. |
|
|
Top Stories Monday, July 29, 2019 Andrew Parker is set to step down as chief scientific officer of Zealand Pharma at the end of next month. Parker gave his notice after receiving an offer from another biotech, leaving Zealand to search for a new CSO. Monday, July 29, 2019 Kodiak Sciences’ anti-VEGF drug improved vision and reduced retinal thickening in patients with wet age-related macular degeneration, diabetic macular edema or macular edema stemming from retinal vein occlusion. Monday, July 29, 2019 Sanofi doesn't see much of a future for diabetes drug Zynquista, so it's exiting a development partnership. But Lexicon is hitting back by saying the company hasn't fulfilled its obligations. Monday, July 29, 2019 New research reveals the protein alpha-synuclein, which has been implicated in some brain disorders, actually plays a vital role in preventing the death of neurons in Parkinson’s. The findings could inspire new treatments. Resources Sponsored by: Veeva This white paper details how leveraging new reporting capabilities, live UAT feedback sessions, and an agile design approach to study builds will save them time and money. Sponsored by: BBK Worldwide The Study Voices survey challenges the myth that physicians won’t refer patients to clinical trials, and it identifies opportunities to engage physicians as partners in the enrollment process. Sponsored by: Cambrex The highest number of NCEs approved by the FDA…the fastest growing small molecule clinical pipeline reported in 20 years…these are exciting times for our industry. Sponsored by: Reprints Desk, Inc. Cut your research time in half - with an easy-to-use app for scientists that combines full-featured reference management with integrated search and on-demand document delivery. Sponsored by: Almac Group Innovative Just in Time Manufacturing solution enables sponsors full late stage customisation of clinical trial materials Sponsored by: PwC How are employer activism strategies beginning to replace the cost-sharing of the past, and improve the health of the workforce? Sponsored by: United Cargo and SAVSU Technologies The combination of SAVSU technology with United Airlines’ global network has made it easier than ever to bring cell and gene therapies to destinations beyond major markets. Sponsored by: XiltriX North America Find out in this article how your pharmaceutical organization can leverage IoT technologies and informatics integration to innovate and improve overall operational efficiencies. Sponsored by: Patheon, by Thermo Fisher Scientific When a biologics company prepares to launch a new product, it must forecast the manufacturing capacity it will need. Learn more here. Sponsored by: Veradigm Patient demand for more information on their care is driving new e-prescribing regulations, and technology is evolving to help providers meet them. This report provides an overview of key areas where such regulation has emerged, and what it could mean for providers and healthcare IT companies. Sponsored by: Patheon, by Thermo Fisher Scientific Anticipate challenges in formulation early. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. | 
